Bottom line: small aromatherapy trials report possible improvements in selected menopause symptoms, stress or sleep. The evidence is too varied and fragile to treat essential oils as hormone therapy or a general menopause treatment.
This guide separates particular oils, routes and outcomes. It does not recommend stopping prescribed treatment or using essential oils internally.
Menopause is not one outcome
The NHS describes hot flushes, night sweats, sleep disturbance, mood changes, vaginal symptoms and altered bleeding among many possible experiences. One study rarely addresses all of them.
An intervention that changes a short stress score has not necessarily reduced hot flush frequency. Better sleep does not prove a hormonal effect.
Perimenopause, menopause and postmenopause also describe different stages. Study populations should not be combined without checking who was enrolled.
What reviews of aromatherapy have found
A 2021 systematic review found potentially favourable effects from aromatherapy in menopausal women. The included trials differed in oils, delivery, duration and outcomes.
A 2025 review again reported possible benefits while identifying methodological weaknesses and heterogeneity. Pooling small, different studies cannot create a standard treatment protocol.
A 2020 systematic review reported possible benefits from lavender aromatherapy for several menopausal outcomes. High heterogeneity and the need for better adverse-event reporting restricted confidence.
These reviews make aromatherapy worth studying. They do not show that any essential oil works for every symptom or is comparable with established treatments.
Lavender and hot flushes
A controlled trial studied inhaled lavender for menopausal hot flushes. Participants reported a reduction relative to control during the study period.
Hot flush reporting is subjective and can change with expectation, attention and natural fluctuation. Blinding a recognisable scent is particularly difficult.
Another randomised trial examined lavender aromatherapy across menopause symptom scores. A combined questionnaire can improve even when specific symptoms respond differently.
The studies do not establish the best species, chemical profile, device, concentration or long-term schedule. They also do not show that any lavender product will reproduce the results.
Neroli and psychological outcomes
A trial of neroli-oil inhalation in postmenopausal women examined symptoms, stress and selected physiological measures. Some outcomes favoured the aroma condition.
The study was small and used a specific exposure. It cannot establish treatment of anxiety disorders, hypertension or sexual dysfunction.
A short-term physiological change also needs cautious interpretation. It may reflect rest, breathing, attention or scent preference rather than a durable clinical effect.
Massage trials contain two interventions
A randomised trial reported improvement after aromatherapy massage in menopausal women. Touch, time, setting, carrier oil and fragrance all form part of that intervention.
A massage study cannot tell us that diffusing the same oil will have the same effect. It may not isolate the essential oil from massage either.
This is not a reason to dismiss massage. It is a reason to describe the tested package accurately.
Sleep studies answer a narrower question
A pilot trial combined lavender essential oil with a sleep-hygiene protocol in postmenopausal women. Any improvement cannot automatically be attributed to the oil alone.
Another randomised trial explored lavender aromatherapy for insomnia in postmenopausal women. Its population and outcome were sleep-specific.
Poor sleep during menopause can reflect hot flushes, mood, pain, medicines, sleep apnoea or unrelated insomnia. Persistent symptoms deserve an assessment rather than a single fragrance solution.
Clary sage and “hormone balancing”
One study measured salivary oestrogen after exposure to several essential oils, including clary sage. A biomarker response does not show symptom relief, safety or correction of a hormone deficiency.
A small clary-sage experiment also examined cortisol and serotonin-related measures in postmenopausal women. It was not a treatment trial for the full menopause syndrome.
“Balances hormones” is not a defined outcome. It should not be inferred from salivary measures or laboratory mechanisms.
Compare with established guidance
NICE guideline NG23 covers diagnosis and management of menopause. It addresses hormone therapy, non-hormonal options, psychological support, genitourinary symptoms and individual risk.
Benefits and risks depend on symptoms, age, health history and treatment. Essential oils do not replace that individual discussion.
The NHS describes treatment options and practical support. It also advises seeking help when symptoms affect daily life.
Safety and reasons to seek care
Do not swallow essential oils or apply them undiluted to the vulva or vagina. Concentrated fragrance can irritate skin and mucosal tissue.
Essential oils are recognised causes of allergic contact dermatitis. Stop a product that causes persistent redness, swelling, itching or blistering.
Bleeding after 12 months without a period needs medical assessment. New chest pain, severe breathlessness or sudden neurological symptoms also need urgent care.
Ask a pharmacist or clinician about interactions and product-specific safety, especially during cancer treatment or when a hormone-sensitive condition affects treatment choices.
My verdict
Aromatherapy may offer a pleasant supportive ritual, and a few short trials report symptom improvements. Confidence remains limited by small samples, scent blinding, mixed interventions and inconsistent outcomes.
It should be described as optional supportive care, not hormone balancing. Use established guidance to identify the cause and treatment options for symptoms that matter.
References
- NHS: Symptoms of menopause and perimenopause
- NHS: Menopause treatment
- NICE NG23: Menopause identification and management
- Systematic review of aromatherapy for menopausal symptoms
- 2025 systematic review of aromatherapy in menopause
- 2020 systematic review of lavender aromatherapy and menopause
- Lavender inhalation trial for hot flushes
- Lavender trial using menopause symptom scores
- Neroli inhalation trial in postmenopausal women
- Aromatherapy-massage trial in menopausal women
- Lavender plus sleep-hygiene pilot trial
- Lavender aromatherapy trial for postmenopausal insomnia
- Essential-oil exposure and salivary oestrogen study
- Clary sage, cortisol and serotonin-related measures
- Contact allergy to essential oils